英語 での Statistically significant difference の使用例とその 日本語 への翻訳
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
-
Programming
However, the single trial comparing colesevelam to placebo only(33 participants) did not reveal a statistically significant difference between the two arms- in fact, in both arms HbA1c increased.
しかし、コレセベラムをプラセボ単独と比較した1件の試験（参加者33名）では、2群間に統計学的有意差はみられず、実際のところ両群でHbA1cが上昇した。Comparing yoga groups to control groups, there was a statistically significant difference in overall health-related quality of life, depression, anxiety and gastrointestinal symptoms.
ヨガ群とコントロール群を比較すると、全体的な健康関連生活の質（QOL）、うつ、不安、消化器症状において統計的に有意な差があった。For these patients, there was no statistically significant difference in DFS between those who received HSCT(n= 66) and those who received chemotherapy only(n= 88), after adjusting for waiting time to HSCT(5.7 months).
これらの患者でHSCTまでの待機期間（5.7ヵ月）について調整した後、HSCTを受けた患者（n=66）と化学療法のみを受けた患者（n=88）ではDFSに統計的有意差は認められなかった。There was no statistically significant difference in non-verbal communicative skills outside of the therapy context(SMD 0.48, 95% CI -0.02 to 0.98, 3 RCTs, n= 57, low quality evidence).
療法の場面以外での非言語的コミュニケーションスキルでは、統計学的な有意差は認められなかった（SMD0.48、95％CI-0.02～0.98、3件のRCT、n=57、質の低いエビデンス）。For this study there was no statistically significant difference between the meditation therapy group
この研究では、教師評価型のADHD評価尺度に関して、瞑想療法群と薬物療法群の間で統計学的有意差は認められなかった（MD-2.72,A statistically significant difference in 5-year survival by histopathologic subtype(82% for embryonal rhabdomyosarcoma vs. 65% for alveolar rhabdomyosarcoma), was not noted when 1,258 IRS-III and IRS-IV patients with rhabdomyosarcoma were analyzed.[43].
IRS-IIIおよびIRS-IVの横紋筋肉腫患者1,258人について解析したところ、5年生存率では病理組織学的亜型による統計的に有意な差は認められなかった（胎児型横紋筋肉腫で82％vs胞巣型横紋筋肉腫で65％）。[46]。In a second trial that compared ECF with mitomycin, cisplatin, and 5-FU(MCF), there was no statistically significant difference in median survival(9.4 vs. 8.7 months, P= .315).
ECFとマイトマイシン、シスプラチン、5-FU（MCF）を比較した2つ目の試験では、生存期間中央値に関して統計的有意差は認められなかった（9.4vs8.7ヵ月、P=0.315）。However, a different Australian randomized study(the Nambour Skin Cancer Prevention Trial) showed that, after 4.5 years of follow-up, there was no statistically significant difference in the incidence of BCCs or SCCs with regular SPF 16 sunscreen use.
しかしながら、別のオーストラリアのランダム化研究（NambourSkinCancerPreventionTrial）では、SPF16のサンスクリーン常用により、4.5年の追跡調査後のBCCまたはSCCの発生率に統計的な有意差は認められなかった。Although the results of Study 761 showed a trend for mecobalamin(both 25 mg and 50 mg groups) of a longer time to event and a trend in slowing the decline in ALSFRS-R scores when compared to placebo, a statistically significant difference could not be confirmed.
試験において、メコバラミン投与群(25mg及び50mg投与群)では、プラセボ投与群に比較してイベント発生までの期間の延長傾向とALSFRS-Rスコアの低下抑制傾向がみられましたが、統計学的有意差は確認できませんでした。A single asterisk signifies a statistically significant difference between a group receiving radiation and the un-irradiated controls, two asterisks indicate a statistically significant difference between the group treated with eritoran on days 0-3, and the placebo controls(irradiated)(P=0.041).
単一アスタリスクは放射線を受けたグループと放射処理していない対照との間に統計学的に有意な差異のあることを表し、２つのアスタリスクは０〜３日目にeritoranで処理したグループとプラシーボ対照（未放射）との間に統計学的に有意な差異のあることを表す（P=0.041）。A trend for better EFS with GM-CSF and 3F8 anti-GD2 antibody therapy and autologous SCT was observed(65% vs. 51%, P= .128), but there was no statistically significant difference in OS between those treated with chemotherapy alone and those treated with autologous SCT.
GM-CSFおよび3F8抗GD2抗体療法と自家SCTの併用群ではEFSが良好な傾向が観察された（65％vs51％、P=0.128）が、化学療法単独で治療された患者と自家SCTで治療された患者間でOSにおける統計的有意差は認められなかった。Statistically significant differences between 2012 and 2014 were not found.
年の間に統計的に有意な変化はみられなかった。There were no statistically significant differences in the change FACIT-Sp scores at 3 months, but differences did emerge at 4 months;
ヵ月経過時のFACIT-Spスコアの変化について統計的有意差は認められなかったが、4ヵ月経過時には差が生じた；。No statistically significant differences were found for lower-limbs circumferences in any time points(Table 1).
However, no statistically significant differences in patient-reported outcomes or resource use.
しかしながら、患者が報告する治療成績または資源の利用について統計的有意差は認められなかった。No statistically significant differences in OS between the placebo- and bevacizumab-containing arms were observed.
OSでは、プラセボ群とベバシズマブ含有群間に統計的有意差は認められなかった。Use the Means table to understand the statistically significant differences between the factor levels in your data.
平均表を使い、データ内の因子水準間の統計的に有意な差を把握します。Women in the high-dose group reported significantly worse quality-of-life scores immediately after treatment, but few statistically significant differences were found between the groups by 1 year.
高用量群の女性は治療直後の生活の質スコアが著しく低いことが報告されていたが、1年目までに群間の統計的有意差はほとんどなくなった。Comparing recipients who were 60 to 65 with those older than 66, there were no statistically significant differences in overall survival at four years or in four-year survival without disease progression.
歳の患者を66歳以上の患者と比較した結果、4年全生存率や4年無増悪生存率で統計的な有意差は認められなかった。Women in the high-dose group reported significantly worse quality-of-life scores immediately after treatment, but there were few statistically significant differences between the groups by one year.
高用量群の女性は治療直後の生活の質スコアが著しく低いことが報告されていたが、1年目までに群間の統計的有意差はほとんどなくなった。
